中国における胃がん,1990年から2023年:傾向,変更可能なリスク,予防の優先事項
Shuai Wang1, Jingbo Lv2, Li Wang1
1Department of Gastric and Colorectal Surgery, General Surgery Center, The First Hospital of Jilin University.
Journal of clinical gastroenterology
|February 20, 2026
まとめ
中国における胃がん (GC) の負担は,死亡率の低下を示しているが,特に高齢の男性では症例数が増加している. 強化されたリスクファクター管理と標的型スクリーニングは,このシフトを管理するために不可欠です.
科学分野:
- エピデミオロジー エピデミオロジー
- 公衆衛生は公衆衛生である.
- 腫瘍学 腫瘍学
背景:
- 胃がん (GC) は,中国における癌による死亡の重要な原因である.
- GCの発生率,死亡率,流行率,およびDALYの長期的な傾向は定量化する必要があります.
研究 の 目的:
- 1990年から2023年までの中国におけるGC発生率,死亡率,流行率,およびDALYの長期的な傾向を定量化する.
- GCに関連した主要な行動リスクに起因する負担をプロファイルする.
主な方法:
- 疾病,怪我,およびリスクファクターのグローバル負担の活用研究 (GBD) の2023年の中国の見積もり.
- 雇用者ジョインポイントのログ・リニア回帰により,年齢標準化率 (ASIR,ASMR,ASPR,ASDR) の傾向を性別および年齢別で分析する.
主要な成果:
- 2023年,中国は575,712件のGC症例と381,500件の死亡を記録しました.
- 1990年以来,死亡者数とDALYが著しく減少した一方で,インシデントおよび流行の症例は増加した.
- 男性と75歳以上の個人が,最も高く,最もゆっくりと減少するGC負荷を経験しました;喫煙,高ナトリウム,アルコール摂取が主な要因でした.
結論:
- 中国のGCの負担は,より低い死亡率,より高い症例数,高齢の男性に集中する方向にシフトしています.
- 喫煙,高ナトリウム,アルコールの消費などの危険因子の制御を強化することが不可欠です.
- リスクに適応した内視鏡検査のスクリーニング戦略は,変化するGCの状況に対処するために不可欠です.
さらに関連する動画
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.6K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
1.7K
関連する概念動画
Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Barrett Esophagus-I: Introduction
992
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
992
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
Cancer
54.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.8K
